Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAfter injecting the first dose of Wegovy, the pen's plunger will have moved and the dose window typically shows a change in indicator position — but the pen itself is not empty. Each Wegovy pre-filled pen contains four weekly doses, so after one injection you still have three remaining. That's the most common misunderstanding our prescribers hear, and it's worth clearing up before it leads to a wasted pen or a missed week. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses suitability before treatment is issued, and the Patient Information Leaflet that comes with your pen is the definitive guide to using it correctly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Many people pick up their first Wegovy pen expecting it to be a single-use device, like the ones used for some other medicines. It isn't. The standard Wegovy pre-filled injection pen is designed to deliver four separate once-weekly doses from a single cartridge. After your first injection, the plunger will have advanced and the indicator will show that one dose has been used. The pen is not finished. There are three more weekly doses in that same pen.
This matters because discarding the pen early is an expensive mistake, and because trying to get a replacement mid-cycle may not be straightforward. If the dose window or plunger position confused you on first use, you are far from alone. The pen's mechanism is designed for reliability, not necessarily for instant intuition. Reading the leaflet before your first injection, rather than after, makes the whole process considerably less alarming.
For more on what to expect in the days following that first injection, the guide to your Wegovy first dose covers the practical side in detail, including the tolerability reasons the starting dose is set lower than the eventual maintenance dose.
Wegovy's pre-filled pen has a dose counter or indicator window. Before any doses are used, it reads at the starting position. After each weekly injection, the counter advances by one step. After your first dose, it moves to show one dose used; after two, it moves again. The plunger inside the cartridge also advances slightly with each dose, this is normal and does not indicate a fault or an empty pen.
Some people notice a small amount of liquid near the needle tip after removing the pen from the skin. A drop or two is not a sign the dose failed; this is common with subcutaneous injections and the amount involved is negligible relative to the dose delivered. If, however, the dose counter did not change at all after you injected, or you saw the entire contents discharge outside the skin, contact your prescriber or check the Patient Information Leaflet, both scenarios warrant a conversation before you take another dose.
Storage makes a difference here too. The pen should go straight back into the fridge at 2–8°C between uses, some people keep it in the fridge door, which works well provided the temperature in that compartment stays consistent. Keep the cap on and store it away from the freezer compartment; freezing ruins the medicine. If you want to understand exactly what the Wegovy pen looks like after one dose, including how the indicator and plunger position change, that detail is covered in full. The what the pen looks like after two doses page continues this sequence if you want to follow the progression.
After the fourth and final injection from one pen, the dose counter reaches zero (or the equivalent end marker for your pen format). At that point, the pen is genuinely finished and should be disposed of in an approved sharps container. You should then open your next pen for the following week's dose.
This is also the point at which your prescriber may consider moving to the next dose strength, depending on how you have tolerated the current level. The titration schedule for Wegovy moves from lower to higher doses over several months; the full Wegovy dose schedule explains each step and what drives the timing. Dose increases are a clinical decision, not something to self-manage based on how the pen indicator looks. If you are approaching the end of your first pen and wondering what comes next, that question is better directed to your prescriber than to the counter window.
A note on cost context: if you are thinking about the financial side of continuing treatment, private Wegovy pricing varies by dose and provider, and understanding what a quoted price actually covers is useful before committing to a course.
Before each dose, glance at the dose counter to confirm doses remain. Check the liquid in the cartridge window: it should be clear to slightly opalescent (faintly cloudy) and colourless to pale yellow, do not inject if you see particles, strong discolouration or anything that looks crystallised. Inspect the pen tip; attach a new needle each time.
If anything looks wrong, the right move is to set the pen aside and contact your prescriber or call 111 rather than injecting something you are uncertain about. Reporting unexpected reactions to the pen itself is also possible through the MHRA's Yellow Card scheme, which accepts reports from patients directly. The NHS semaglutide medicines page covers what to look for and when to seek help in straightforward terms.
If you have questions that go beyond what the leaflet covers, our aftercare team is available seven days a week. For anyone still working out whether Wegovy is the right route for them, checking eligibility through a free consultation is the place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.